| Author | Post |
|---|
SBS in Santa Fe
Member
| Joined: | Sun Jun 21st, 2009 |
| Location: | New Mexico USA |
| Posts: | 2 |
| Status: |
Offline
|
|
Posted: Tue Jun 23rd, 2009 19:15 |
|
I need a description of the therapeutic probe and exactly what I will be asking my Dr to prescribe.
Please advise.
Thanks
|
DNStog
Moderator
|
Posted: Wed Jun 24th, 2009 06:24 |
|
By typing Therapeutic probe in the search engine, I came up with the link below. Scroll down to the "red" lettering and it explains how to do it.
WhatIsATherapeuticProbe ---Regards..Donna
____________________
MP started 12-27-04
Sarcoidosis Systemic/Uveitis/ Hypothyroidism/ Raynaud's Phen/Paraesthesia/rhinosinusitis/ asthma/depression
|
paulalbert
Moderator
| Joined: | Fri Oct 26th, 2007 |
| Location: | |
| Posts: | 94 |
| Status: |
Offline
|
|
Posted: Mon Jun 29th, 2009 20:26 |
|
Here's is the updated KB article on the subject:
http://mpkb.mp-dev.com/doku.php/home:starting:therapeutic_probe
Best,
Paul
|
DNStog
Moderator
|
Posted: Tue Jun 30th, 2009 05:00 |
|
| Thanks, Paul...a great improvement!!! --Donna
____________________
MP started 12-27-04
Sarcoidosis Systemic/Uveitis/ Hypothyroidism/ Raynaud's Phen/Paraesthesia/rhinosinusitis/ asthma/depression
|
Alejandro
Member
| Joined: | Mon Nov 17th, 2008 |
| Location: | Germany |
| Posts: | 50 |
| Status: |
Offline
|
|
Posted: Thu Aug 13th, 2009 20:06 |
|
I have read the new version but I have still questions. Does it mean the 25mg Mino and Benicar (40mg every 6-8h) should be started on the same time ?
Thanks a lot
Alejandro
____________________
-------------------
Skin Sarcoidosis treated with Corticoid creme 1,25 D3 : 41 pg/ml (was 63) 25 D : 10 ng/ml (was 22)
In MP since Dec 2009
|
paulalbert
Moderator
| Joined: | Fri Oct 26th, 2007 |
| Location: | |
| Posts: | 94 |
| Status: |
Offline
|
|
Posted: Fri Aug 14th, 2009 19:34 |
|
If your goal is to see if you can generate a reaction suggesting immunopathology, I would start both at the same time. But I'm positive about this....
Paul
|
Current time is 14:11 | |
|
